reports
HEXO sees a downgrade to Negative on account of less fundamental stars
The independent financial analyst theScreener just lowered the general evaluation of HEXO (CA), active in the Pharmaceuticals industry. As regards its fundamental valuation, the title now shows 1 out of 4 stars while market behaviour can be considered risky. theScreener believes that the title remains under pressure due to the loss of a star(s) and downgrades its general evaluation to Negative. As of the analysis date October 30, 2020, the closing price was CAD 0.81 and its target price was esti...
After Explorers, Sprott Now Moves to Gold Producers
The Vancouver Resource Investment Conference (VRIC) is the World's Largest Resource Investment Event with over 350 companies, 9000 investors and 100 top speakers. The 2020 Event takes palce January 19th & 20th, at the Vancouver Convention Centre West. Register today at
HEXO Corp. announces proposed public offering of common shares
HEXO Corp. announces proposed public offering of common shares GATINEAU, Quebec, Jan. 21, 2019 (GLOBE NEWSWIRE) -- HEXO Corp. (“HEXO” or the “Company”) (TSX: HEXO) today announced that it will be filing a preliminary prospectus supplement (the “Preliminary Supplement”) to its amended and restated short form base shelf prospectus dated December 14, 2018 (the “Base Shelf Prospectus”) relating to a proposed marketed public offering of common shares of the Company for gross proceeds of approximately C$50 million (the “Offering”). The Offering will be priced in the context of the market with t...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.